INS and obesity disorder: In adipose tissue in obesity, the activation of this pathway results in insulin resistance through IKK-mediated serine phosphorylation of IRS-1 or insulin receptor, leading to the inhibition of insulin-induced serine phosphorylation and downstream signaling [104].